(Bloomberg) — Global oil prices could reach a “stratospheric” $380 a barrel if US and European penalties prompt Russia to inflict retaliatory crude-output cuts, JPMorgan Chase & Co. analysts warned. The Group of Seven nations are hammering out a complicated mechanism to cap the price fetched by Russian oil in a bid to tighten the […]
Read MoreAltimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company’s lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatitis. ALT $11.2000 -0.5000 % -4.2700 Altimmune Inc […]
Read MoreThe Chefs’ Warehouse, Inc. (CHEF) The Chefs’ Warehouse, Inc., together with its subsidiaries, engages in distribution of specialty food products in the United States and Canada. The company’s product portfolio includes approximately 50,000 stock-keeping units. The J. M. Smucker Company (SJM) The J. M. Smucker Company manufactures and markets branded food and beverage products worldwide. […]
Read MorePetIQ, Inc. (PETQ) PetIQ, Inc. operates as a pet medication and wellness company in the United States and internationally. It operates in two segments, Products and Services. The company offers Rx pet medications, which include flea and tick control, heartworm preventatives and much more. Arrowhead Pharmaceuticals, Inc. (ARWR) Arrowhead Pharmaceuticals, Inc. develops medicines for the […]
Read MoreBuy Price: $2.95 or better Sell Price: TradersPro Sell Signal Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product. The stocks founds in the One Hot Stock category […]
Read MoreDuring the early stages of the COVID-19 pandemic, one of the sectors of market that experienced major shifts in its business models was the Healthcare sector. The entire system – local clinics, hospitals, and more – had to conform to the mass amount of patients, making the sector consider several alternatives. Public and market focus, […]
Read MoreThe current high inflation environment is often compared to the 1970s. But perhaps a more apt comparison would be to the 1870s. According to Bank of America, government bonds are on track for their worst year since 1865, the year the U.S. Civil War ended. Meanwhile, the stock market, when adjusted for inflation, is on […]
Read More(Bloomberg) — Elon Musk’s fortune plunged almost $62 billion. Jeff Bezos saw his wealth tumble by about $63 billion. Mark Zuckerberg’s net worth was slashed by more than half. All told, the world’s 500 richest people lost $1.4 trillion in the first half of 2022, a dizzying decline that marks the steepest six-month drop ever […]
Read More(Bloomberg) — A “recession shock” begins for markets following the worst first-half for the S&P 500 in more than 50 years, Bank of America Corp.’s Chief Investment Strategist Michael Hartnett says. While expectations of aggressive rate hikes by the Federal Reserve are peaking, inflation expectations are not, and Bofa’s bull and bear indicator remains at […]
Read More(Bloomberg) — Investors cut holdings in exchange-traded funds for silver, platinum and palladium in the second quarter on fears that a potential recession will reduce industrial demand, but gold assets held up because of its role as a haven, and that may persist. Gold-backed ETFs shrank by just over 1% in the three months through […]
Read More(Bloomberg) — Micron Technology Inc. gave a surprisingly downbeat forecast for the current quarter after demand for phones and computers weakened, but vowed to move aggressively to stave off a chip glut. The company — the largest US maker of memory semiconductors — warned that sales will be about $7.2 billion in its fiscal fourth […]
Read More